These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18929791)

  • 1. Indication for splenectomy in the era of living-donor liver transplantation.
    Jeng LB; Lee CC; Chiang HC; Chen TH; Hsu CH; Cheng HT; Lai HC
    Transplant Proc; 2008 Oct; 40(8):2531-3. PubMed ID: 18929791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of graft size on postoperative thrombocytopenia in living donor liver transplant.
    Marubashi S; Dono K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    Arch Surg; 2007 Nov; 142(11):1054-8. PubMed ID: 18025333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation.
    Sato Y; Yamamoto S; Oya H; Nakatsuka H; Tsukahara A; Kobayashi T; Watanabe T; Hatakeyama K
    Hepatogastroenterology; 2002; 49(48):1652-5. PubMed ID: 12397756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevent small-for-size syndrome using dual grafts in living donor liver transplantation.
    Chen Z; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J
    J Surg Res; 2009 Aug; 155(2):261-7. PubMed ID: 19481224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated liver transplantation for decompensated end-stage liver disease in children with intestinal failure.
    Ventura K; Rekhtman Y; Jan D; Emond J; Lobritto S
    Transplant Proc; 2006; 38(6):1699-701. PubMed ID: 16908253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I; Gruttadauria S; Nadalin S; Viganò J; di Francesco F; Pietrosi G; Fili' D; Montalbano M; D'Antoni A; Volpes R; Arcadipane A; Vizzini G; Gridelli B
    Transplant Proc; 2008; 40(6):1976-8. PubMed ID: 18675105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and problems of adult ABO-incompatible living donor liver transplantation using protocol of plasma exchange, intra-arterial infusion therapy, and anti-CD20 monoclonal antibody without splenectomy: case reports of initial experiences and results in Korea.
    Kim BW; Park YK; Kim YB; Wang HJ; Kim MW
    Transplant Proc; 2008 Dec; 40(10):3772-7. PubMed ID: 19100487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for acute hepatic failure.
    Wu YM; Ho MC; Hu RH; Ko WJ; Yang PM; Lai MY; Lee PH
    Transplant Proc; 2004 Oct; 36(8):2226-7. PubMed ID: 15561199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
    Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
    Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G; Vidanovic V; Chejfec G; Gangemi A; Iqpal R; Porubsky M; Pham T; Benedetti E
    Transplantation; 2008 Mar; 85(5):681-6. PubMed ID: 18337660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
    Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
    Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation.
    Kim BS; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH
    Transplant Proc; 2009; 41(1):250-2. PubMed ID: 19249527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
    Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of splenectomy in living-donor liver transplantation for adults.
    Cescon M; Sugawara Y; Takayama T; Seyama Y; Sano K; Imamura H; Makuuchi M
    Hepatogastroenterology; 2002; 49(45):721-3. PubMed ID: 12063978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience.
    Sotiropoulos GC; Lang H; Saner FH; Beckebaum S; Wandelt M; Molmenti EP; Nadalin S; Treckmann J; Bockhorn M; Fouzas I; Malagó M; Gerken G; Broelsch CE; Paul A
    Transplant Proc; 2008 Nov; 40(9):3196-7. PubMed ID: 19010232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.